Overview
Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)
Status:
Completed
Completed
Trial end date:
2007-07-01
2007-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study is an open label, noncomparative study using an investigational agent for the treatment of documented Candida or Aspergillus infections in pediatric patients (ages 3 months-17 years).Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Caspofungin
Echinocandins
Criteria
- Children, 3 months through 17 years of age,- with esophageal candidiasis or
- invasive candidiasis or
- children requiring salvage treatment of invasive aspergillosis.